Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Dar Global

    MCap

    USD1,486m

    Last close

    USD8.25

    ▲ −0.25 (−2.94%)

    Theon International

    MCap

    EUR875m

    Last close

    EUR12.50

    ▲ 1.44 (13.02%)

    Metals One

    MCap

    GBP2m

    Last close

    GBP0.00

    ▲ 0.04 (8.89%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Executive interview – Herantis

Executive interview – Herantis

Herantis Pharma was created by a merger of two Finnish pharmaceutical companies, Hermo Pharma and Laurantis Pharma. Its research is a result of scientific discoveries made by Professor Mart Saarma and Professor Kari Alitalo at the University of Helsinki. Herantis listed on NASDAQ OMX Helsinki First North Finland in 2014. In this video, CEO Pekka Simula introduces the company and its assets, including its CDNF asset which is under clinical investigation for Parkinson’s disease and utilises the same drug-delivery device highlighted in a recent BBC documentary on GDNF.

< Previous
Next >

You may also be interested in these:

Investment Companies

Vantage: Gresham House Energy Storage Fund – Navigating challenges in energy storage

TMT

IP Group – executive interview

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free